| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA874428 | Binding | Maximum percent of enhancement of binding. | 31 | ALA1123034 | protein complex format | Scientific Literature | ||
| 2. | ALA633999 | Binding | Maximum percent of inhibition of binding was determined | 30 | ALA1123034 | protein complex format | Scientific Literature | ||
| 3. | ALA634000 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1 | 4 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 4. | ALA634001 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-4 | 6 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 5. | ALA634002 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-5 | 5 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 6. | ALA634003 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-6 | 8 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 7. | ALA634004 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-7 | 1 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 8. | ALA634005 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-8-10e-4 | 1 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 9. | ALA636020 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-9-10e-4 | 1 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 10. | ALA636021 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-9-10e-6 | 1 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 11. | ALA632851 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-4 | 1 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 12. | ALA632852 | Binding | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-6 | 1 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 13. | ALA632853 | Binding | Ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 2 | 29 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 14. | ALA632854 | Binding | Compound was evaluated for its ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-9-10e-11 | 1 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 15. | ALA636099 | Binding | Ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 3. | 16 | ALA1123034 | tissue-based format | Scientific Literature | ||
| 16. | ALA636100 | Binding | Compounds was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 4 | 2 | ALA1123034 | assay format | Scientific Literature | ||
| 17. | ALA636101 | Binding | Compounds was evaluated in vitro for ability to enhance and inhibit the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-3 | 1 | ALA1123034 | assay format | Scientific Literature | ||
| 18. | ALA636102 | Binding | Compounds was evaluated in vitro for ability to enhance and inhibit the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 4 | 1 | ALA1123034 | assay format | Scientific Literature | ||
| 19. | ALA639518 | Binding | Compounds was evaluated in vitro for ability to enhance and inhibit the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 5 | 1 | ALA1123034 | assay format | Scientific Literature | ||
| 20. | ALA639519 | Binding | Compound was evaluate for its ability to enhance (+/-)-[3H]nicotine binding at a dose range 10e-11 M to 10E-8 M was reported | 1 | ALA1123034 | protein complex format | Scientific Literature |
The page will load shortly, Thanks for your patience!